Europe's aversion to GM crops has killed investors' appetites for agricultural research. Even in the UK, historically a world leader in this field, it is almost impossible to commercialise agricultural biotechnology of any kind.
As the countries of the European Union struggle to meet their targets for R&D growth, they are looking at new tax breaks for entrepreneurs. Good news, or too little too late?
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.